{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T02:01:06Z","timestamp":1769738466596,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK094929"],"award-info":[{"award-number":["P30DK094929"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Clinical trials of adults with prediabetes demonstrate that metformin can prevent or delay the risk of developing type 2 diabetes by approximately 30%. The association between socioeconomic disadvantage and elevated diabetes risk underscores the importance of using metformin in this high-risk group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine the prevalence of metformin prescriptions among patients with prediabetes served by federally qualified health centers (FQHCs), the largest national system of primary care clinics in socioeconomically disadvantaged communities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective cohort study using 2008\u20132019 electronic health record data from a national FQHC network.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Patients with prediabetes were identified by the presence of:\u2009\u2265\u20091 diagnosis code; or\u2009\u2265\u20092 glycemic test results in the prediabetes range. We excluded patients with prior metformin prescription orders and those with prior evidence of diabetes by diagnosis code or two glycemic test results in the diabetes range.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Measures<\/jats:title>\n                    <jats:p>We examined metformin prescription orders, overall, and by patient characteristics including age and body mass index (BMI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Results<\/jats:title>\n                    <jats:p>A total of 59,232 FQHC patients were found to have prediabetes, of whom 48.4% reported Hispanic ethnicity, 27.2% reported Black race, 22.5% had Medicaid insurance, and 33.1% were uninsured. Within one and five years of prediabetes diagnosis, metformin was prescribed for 3.0% and 6.1% of patients, respectively. In multivariate analyses, increasing BMI was the strongest predictor of metformin prescription orders. Disparities in metformin prescription rates were observed among FQHCs patients from racial minority groups relative to White patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Metformin prescriptions for prediabetes are rare among FQHC patients. Prescribing rates were higher among patients with elevated BMI, and lower among patients from racial minority groups. Further research is needed to understand reasons for low metformin use in this population and promote clinical guidelines for diabetes prevention in FQHCs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11606-025-09459-w","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T11:54:29Z","timestamp":1745495669000},"page":"169-176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Metformin Prescription Orders among Patients with Prediabetes in a National Network of Federally Qualified Health Centers"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4522-0811","authenticated-orcid":false,"given":"Tamkeen","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay","family":"Zasadzinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Owen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"9459_CR1","unstructured":"Centers for Disease Control and Prevention. National Diabetes Statistics Report website. Published 2023. Accessed 25 Nov 2023."},{"issue":"9702","key":"9459_CR2","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","volume":"374","author":"Diabetes Prevention Program Research Group","year":"2009","unstructured":"Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss\u00a0in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677-1686.","journal-title":"Lancet"},{"issue":"2","key":"9459_CR3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jacc.2011.03.025","volume":"58","author":"J Yeboah","year":"2011","unstructured":"Yeboah J, Bertoni AG, Herrington DM, Post WS, Burke GL. Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2011;58(2):140-146.","journal-title":"J Am Coll Cardiol."},{"key":"9459_CR4","doi-asserted-by":"crossref","unstructured":"Beckles GL. Disparities in the prevalence of diagnosed diabetes\u2014United States, 1999\u20132002 and 2011\u20132014. MMWR Morb Mortal Wkly Rep. 2016;65.","DOI":"10.15585\/mmwr.mm6545a4"},{"issue":"8","key":"9459_CR5","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1001\/jamainternmed.2016.2952","volume":"176","author":"GS Bonilla","year":"2016","unstructured":"Bonilla GS, Rodriguez-Gutierrez R, Montori VM. What we don\u2019t talk about when we talk about preventing type 2 diabetes\u2014addressing socioeconomic disadvantage. JAMA Intern Med. 2016;176(8):1053-1054.","journal-title":"JAMA Intern Med."},{"key":"9459_CR6","unstructured":"KFF. Poverty Rates by Race\/Ethnicity. https:\/\/www.kff.org\/other\/state-indicator\/poverty-rate-by-raceethnicity\/. Published 2024. Accessed 6\u201311\u20132024 2024."},{"key":"9459_CR7","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. 2002."},{"issue":"4","key":"9459_CR8","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.amepre.2018.04.038","volume":"55","author":"T Moin","year":"2018","unstructured":"Moin T, Schmittdiel JA, Flory JH, et al. Review of metformin use for type 2 diabetes prevention. Am J Prev Med. 2018;55(4):565-574.","journal-title":"Am J Prev Med."},{"issue":"8","key":"9459_CR9","doi-asserted-by":"publisher","first-page":"542","DOI":"10.7326\/M14-1773","volume":"162","author":"T Moin","year":"2015","unstructured":"Moin T, Li J, Duru OK, et al. Metformin prescription for insured adults with prediabetes from 2010 to 2012: a retrospective cohort study. Ann Intern Med. 2015;162(8):542-548.","journal-title":"Ann Intern Med."},{"issue":"4","key":"9459_CR10","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3122\/jabfm.2022.04.210485","volume":"35","author":"A Hughes","year":"2022","unstructured":"Hughes A, Khan T, Kirley K, et al. Metformin prescription rates for patients with prediabetes. J Am Board Fam Med. 2022;35(4):821-826.","journal-title":"J Am Board Fam Med."},{"key":"9459_CR11","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s11606-020-06354-4","volume":"36","author":"SL Speaker","year":"2021","unstructured":"Speaker SL, Rastogi R, Sussman TA, Hu B, Misra-Hebert AD, Rothberg MB. Treatment of patients with prediabetes in a primary care setting 2011\u20132018: an observational study. J Gen Intern Med. 2021;36:923-929.","journal-title":"J Gen Intern Med."},{"issue":"4","key":"9459_CR12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.japh.2017.04.008","volume":"57","author":"J Wu","year":"2017","unstructured":"Wu J, Ward E, Threatt T, Lu ZK. Metformin prescribing in low-income and insured patients with prediabetes. J Am Pharm Assoc. 2017;57(4):483-487.","journal-title":"J Am Pharm Assoc."},{"key":"9459_CR13","unstructured":"Health Resources and Services Administration. HRSA Health Center Program.\u00a0https:\/\/bphc.hrsa.gov\/about-health-center-program.\u00a0Accessed 6\u201311\u20132024 2024."},{"key":"9459_CR14","unstructured":"National Association of Community Health Centers. Community Health Centers: Providers, Partners and Employers of Choice. 2024."},{"issue":"24","key":"9459_CR15","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1001\/jama.2019.19365","volume":"322","author":"YJ Cheng","year":"2019","unstructured":"Cheng YJ, Kanaya AM, Araneta MRG, et al. Prevalence of diabetes by race and ethnicity in the United States, 2011-2016. Jama. 2019;322(24):2389-2398.","journal-title":"JAMA"},{"key":"9459_CR16","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. 3. Prevention or delay of diabetes and associated comorbidities: standards of care in diabetes\u20142024. Diabetes Care. 2024;47(Supplement_1):S43-S51.","DOI":"10.2337\/dc24-S003"},{"issue":"16","key":"9459_CR17","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1007\/s11606-023-08402-1","volume":"38","author":"MJ O\u2019Brien","year":"2023","unstructured":"O\u2019Brien MJ, Bailey SC, Gregory DL, et al. Screening for Prediabetes and Diabetes in a National Network of Federally Qualified Health Centers: An Observational Study. J Gen Intern Med. 2023;38(16):3541-3548.","journal-title":"J Gen Intern Med."},{"key":"9459_CR18","doi-asserted-by":"crossref","unstructured":"Nichols GA, Desai J, Lafata JE, et al. Construction of a multisite DataLink using electronic health records for the identification, surveillance, prevention, and management of diabetes mellitus: the SUPREME-DM project. Prev Chronic Dis. 2012;9.","DOI":"10.5888\/pcd9.110311"},{"key":"9459_CR19","unstructured":"World Health Organization. The Asia-Pacific Perspective: Redefining Obesity and its Treatment. 2000."},{"issue":"1","key":"9459_CR20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2337\/dci20-0053","volume":"44","author":"F Hill-Briggs","year":"2021","unstructured":"Hill-Briggs F, Adler NE, Berkowitz SA, et al. Social determinants of health and diabetes: a scientific review. Diabetes Care. 2021;44(1):258.","journal-title":"Diabetes Care."},{"issue":"6","key":"9459_CR21","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.amepre.2016.06.019","volume":"51","author":"NL Fleischer","year":"2016","unstructured":"Fleischer NL, Henderson AK, Wu Y-H, Liese AD, McLain AC. Disparities in diabetes by education and race\/ethnicity in the US, 1973\u20132012. Am J Prev Med. 2016;51(6):947-957.","journal-title":"Am J Prev Med."},{"issue":"17","key":"9459_CR22","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1017\/S1368980018001908","volume":"21","author":"RJ Walker","year":"2018","unstructured":"Walker RJ, Williams JS, Egede LE. Pathways between food insecurity and glycaemic control in individuals with type 2 diabetes. Public Health Nutr. 2018;21(17):3237-3244.","journal-title":"Public Health Nutr."},{"key":"9459_CR23","doi-asserted-by":"crossref","unstructured":"Shan Z, Li Y, Zong G, et al. Rotating night shift work and adherence to unhealthy lifestyle in predicting risk of type 2 diabetes: results from two large US cohorts of female nurses. BMJ. 2018;363.","DOI":"10.1136\/bmj.k4641"},{"key":"9459_CR24","first-page":"1","volume":"17","author":"Lewis JH, Whelihan K, Navarro I, Boyle KR, Team SCSI","year":"2016","unstructured":"Lewis JH, Whelihan K, Navarro I, Boyle KR, Team SCSI. Community health center provider ability to identify, treat and account for the social determinants of health: a card study. BMC Fam Pract. 2016;17:1-12.","journal-title":"BMC Fam Pract."},{"issue":"2","key":"9459_CR25","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2337\/dc13-1223","volume":"37","author":"JA Schmittdiel","year":"2014","unstructured":"Schmittdiel JA, Adams SR, Segal J, et al. Novel use and utility of integrated electronic health records to assess rates of prediabetes recognition and treatment: brief report from an integrated electronic health records pilot study. Diabetes Care. 2014;37(2):565-568.","journal-title":"Diabetes Care."},{"issue":"7","key":"9459_CR26","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2337\/dc16-1509","volume":"40","author":"E Tseng","year":"2017","unstructured":"Tseng E, Yeh H-C, Maruthur NM. Metformin use in prediabetes among US adults, 2005\u20132012. Diabetes Care. 2017;40(7):887-893.","journal-title":"Diabetes Care."},{"key":"9459_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11606-019-05398-5","volume":"35","author":"C Liu","year":"2020","unstructured":"Liu C, Foti K, Grams ME, Shin J-I, Selvin E. Trends in self-reported prediabetes and metformin use in the USA: NHANES 2005\u20132014. J Gen Intern Med. 2020;35:95-101.","journal-title":"J Gen Intern Med."},{"issue":"1","key":"9459_CR28","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.2337\/dc22-0985","volume":"46","author":"TT Chiou","year":"2023","unstructured":"Chiou TT, Ge Y, Romley JA. Trends in metformin use among patients with prediabetes: 2008\u20132020. Diabetes Care. 2023;46(1):e1-e2.","journal-title":"Diabetes Care."},{"issue":"3","key":"9459_CR29","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1001\/amajethics.2022.226","volume":"24","author":"SP Richmond II","year":"2022","unstructured":"Richmond II SP, Grubbs V. How abolition of race-based medicine is necessary to American health justice. AMA J Ethics. 2022;24(3):226-232.","journal-title":"AMA J Ethics."},{"key":"9459_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2022.101979","volume":"29","author":"MJ O'Brien","year":"2022","unstructured":"O'Brien MJ, Vargas MC, Lopez A, et al. Development of a novel clinical decision support tool for diabetes prevention and feasibility of its implementation in primary care. Prev Med Rep. 2022;29:101979.","journal-title":"Prev Med Rep."},{"issue":"1","key":"9459_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2337\/cd17-0049","volume":"36","author":"NR Kandula","year":"2018","unstructured":"Kandula NR, Moran MR, Tang JW, O\u2019Brien MJ. Preventing diabetes in primary care: providers\u2019 perspectives about diagnosing and treating prediabetes. Clin Diabetes. 2018;36(1):59-66.","journal-title":"Clin Diabetes."},{"key":"9459_CR32","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1007\/s11606-019-05245-7","volume":"34","author":"E Tseng","year":"2019","unstructured":"Tseng E, Greer RC, O\u2019Rourke P, et al. National survey of primary care physicians\u2019 knowledge, practices, and perceptions of prediabetes. J Gen Intern Med. 2019;34:2475-2481.","journal-title":"J Gen Intern Med."},{"issue":"6","key":"9459_CR33","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1177\/0145721716666678","volume":"42","author":"MJ O\u2019Brien","year":"2016","unstructured":"O\u2019Brien MJ, Moran MR, Tang JW, et al. Patient perceptions about prediabetes and preferences for diabetes prevention. Diabetes Educ. 2016;42(6):667-677.","journal-title":"Diabetes Educ."},{"issue":"9","key":"9459_CR34","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S2213-8587(24)00182-7","volume":"12","author":"BM McGowan","year":"2024","unstructured":"McGowan BM, Bruun JM, Capehorn M, et al. Efficacy and safety of once-weekly semaglutide 2\u00b7 4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial. Lancet Diabetes Endocrinol. 2024;12(9):631-642.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"9459_CR35","unstructured":"Jastreboff AM, le Roux CW, Stefanski A, et al. Tirzepatide for obesity treatment and diabetes prevention. N Engl J Med. 2024."},{"issue":"16","key":"9459_CR36","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.1007\/s11606-022-07412-9","volume":"37","author":"E Tseng","year":"2022","unstructured":"Tseng E, Durkin N, Clark JM, Maruthur NM, Marsteller JA, Segal JB. Clinical care among individuals with prediabetes in primary care: a retrospective cohort study. J Gen Intern Med. 2022;37(16):4112-4119.","journal-title":"J Gen Intern Med."},{"issue":"1","key":"9459_CR37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.amepre.2021.06.018","volume":"62","author":"AG Mainous III","year":"2022","unstructured":"Mainous III AG, Rooks BJ, Wright RU, Sumfest JM, Carek PJ. Diabetes Prevention in a US Healthcare System: A portrait of missed opportunities. Am J Prev Med. 2022;62(1):50-56.","journal-title":"Am J Prev Med."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09459-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-025-09459-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09459-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T13:04:21Z","timestamp":1769691861000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-025-09459-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["9459"],"URL":"https:\/\/doi.org\/10.1007\/s11606-025-09459-w","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"4 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"No copyrighted material, surveys, instruments, or tools were used in the research described in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permission to Adapt or Reuse any Copyrighted Material:"}},{"value":"The study protocol was approved by Northwestern University\u2019s Institutional Review Board (IRB). (Protocol # STU0020393).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board:"}},{"value":"The authors declare no potential conflicts of interest with respect to research, authorship, or publication of this article. The findings and conclusions of this study are solely the responsibility of the author(s) and do not necessarily represent the official views of, nor an endorsement, by the American Medical Association, or Northwestern University.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest:"}}]}}